Tranexamic acid for treatment of tenecteplase related hemorrhagic conversion

Am J Emerg Med. 2022 Nov:61:229. doi: 10.1016/j.ajem.2022.07.045. Epub 2022 Jul 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antifibrinolytic Agents* / therapeutic use
  • Fibrinolytic Agents / therapeutic use
  • Hemorrhage / drug therapy
  • Humans
  • Tenecteplase / therapeutic use
  • Tissue Plasminogen Activator / therapeutic use
  • Tranexamic Acid* / therapeutic use
  • Treatment Outcome

Substances

  • Tranexamic Acid
  • Tenecteplase
  • Antifibrinolytic Agents
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator